All News Anika Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
25.65 ^USD	-0.23%		+4.40%	+13.20%

May. 30	Caligan Partners Enters into a Cooperation Agreement with Anika Therapeutics	CI
May. 28	Anika Therapeutics Approves $40 Million Share Repurchase Program	MT

Caligan Partners Enters into a Cooperation Agreement with Anika Therapeutics	May. 30	CI
Anika Therapeutics Approves $40 Million Share Repurchase Program	May. 28	MT
Anika Therapeutics, Inc. announces an Equity Buyback for $40 million worth of its shares.	May. 28	CI
Anika Enters into Cooperation Agreement with Caligan Partners	May. 28	GL
Anika Therapeutics, Inc. Announces Board Changes	May. 28	CI
Anika Therapeutics, Inc. authorizes a Buyback Plan.	May. 27	CI
Anika: Q1 Earnings Snapshot	May. 08	AQ
Transcript : Anika Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024	May. 08
Earnings Flash (ANIK) ANIKA THERAPEUTICS Reports Q1 EPS $0.09	May. 08	MT
Earnings Flash (ANIK) ANIKA THERAPEUTICS Reports Q1 Revenue $40.5M, vs. Street Est of $39.1M	May. 08	MT
Anika Therapeutics, Inc. Provides Earnings Guidance for the Fiscal Year 2024	May. 08	CI
Anika Announces CFO Transition	May. 08	AQ
Anika Reports First Quarter 2024 Financial Results	May. 08	AQ
Anika Therapeutics, Inc. Announces Management Changes, Effective June 3, 2024	May. 08	CI
Anika Therapeutics, Inc. Announces CFO Changes	May. 08	CI
Anika Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 08	CI
Anika Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(4)	May. 06	AQ
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	May. 03	GL
Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024	Apr. 18	GL
Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference	Apr. 02	GL

No results for this search